000
| 02490cam 2200433zi 4500 |
---|
001 | 9.921366 |
---|
003 | CaOODSP |
---|
005 | 20240108124357 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 230329t20232019onc o f000 0 eng d |
---|
020 | |a9780660482231 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-249/2023E-PDF |
---|
245 | 00|aReporting adverse events following immunization (AEFI) in Canada : |buser guide to completion and submission of the AEFI reports. |
---|
246 | 10|aUser guide to completion and submission of the AEFI reports |
---|
246 | 17|aUser guide : |bAEFI report form |
---|
250 | |a[April 2023 edition]. |
---|
264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023. |
---|
264 | 4|c©2019 |
---|
300 | |a1 online resource (36 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aCover title. |
---|
500 | |a"Publication date: April 2023." |
---|
500 | |aIssued also in French under title: Déclaration de manifestations cliniques inhabituelles (MCI) à la suite de l'immunisation au Canada : guide de l'utilisateur pour remplir et soumettre les rapports de déclaration de MCI. |
---|
520 | |a"An AEFI is any untoward medical occurrence which follows immunization and which does not necessarily have a casual relationship with the usage of the vaccine. The adverse event may be any unfavourable or unintended sign, abnormal laboratory finding, symptom or disease"--Background, page 3. |
---|
650 | 0|aImmunization|xComplications|zCanada. |
---|
650 | 0|aVaccination|xComplications|zCanada. |
---|
650 | 0|aDrugs|xSide effects|xReporting|zCanada. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
775 | 08|tDéclaration de manifestations cliniques inhabituelles (MCI) à la suite de l'immunisation au Canada : |w(CaOODSP)9.921367 |
---|
794 | |tReporting adverse events following immunization (AEFI) in Canada : |b(October 2023)|w(CaOODSP)9.932167 |
---|
795 | |tReporting adverse events following immunization (AEFI) in Canada : |b2022|w(CaOODSP)9.911403 |
---|
856 | 40|qPDF|s757 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-249-2023-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/reporting-adverse-events-following-immunization/user-guide-completion-submission-aefi-reports.html |
---|